{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:12:43Z","timestamp":1793049163791,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T00:00:00Z","timestamp":1446076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11060-015-1983-y","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T05:25:02Z","timestamp":1446096302000},"page":"473-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas"],"prefix":"10.1007","volume":"126","author":[{"given":"David","family":"Ta\u00efeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Barlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzhang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Pertuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Tchoghandjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Rochette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Zattara-Canoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Figarella-Branger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Metellus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"key":"1983_CR1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0046-8177(97)90075-7","volume":"28","author":"AO Vortmeyer","year":"1997","unstructured":"Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfield EH, Zhuang Z (1997) von Hippel\u2013Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel\u2013Lindau disease. Hum Pathol 28:540\u2013543","journal-title":"Hum Pathol"},{"key":"1983_CR2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ana.20090","volume":"55","author":"AO Vortmeyer","year":"2004","unstructured":"Vortmeyer AO, Yuan Q, Lee YS, Zhuang Z, Oldfield EH (2004) Developmental effects of von Hippel\u2013Lindau gene deficiency. Ann Neurol 55:721\u2013728. doi: 10.1002\/ana.20090","journal-title":"Ann Neurol"},{"key":"1983_CR3","first-page":"7051","volume":"63","author":"AO Vortmeyer","year":"2003","unstructured":"Vortmeyer AO, Frank S, Jeong SY, Yuan K, Ikejiri B, Lee YS, Bhowmick D, Lonser RR, Smith R, Rodgers G, Oldfield EH, Zhuang Z (2003) Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel\u2013Lindau disease. Cancer Res 63:7051\u20137055","journal-title":"Cancer Res"},{"key":"1983_CR4","first-page":"521","volume":"31","author":"M Nordstrom-O\u2019Brien","year":"2010","unstructured":"Nordstrom-O\u2019Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH (2010) Genetic analysis of von Hippel\u2013Lindau disease. Hum Mutat 31:521\u2013537. doi: 10.1002\/humu.21219","journal-title":"Hum Mutat"},{"key":"1983_CR5","first-page":"4845","volume":"54","author":"H Kanno","year":"1994","unstructured":"Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M (1994) Somatic mutations of the von Hippel\u2013Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845\u20134847","journal-title":"Cancer Res"},{"key":"1983_CR6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/NEN.0000000000000024","volume":"73","author":"LA Muscarella","year":"2014","unstructured":"Muscarella LA, la Torre A, Faienza A, Catapano D, Bisceglia M, D\u2019Angelo V, Parrella P, Coco M, Fini G, Tancredi A, Zelante L, Fazio VM, D\u2019Agruma L (2014) Molecular dissection of the VHL gene in solitary capillary hemangioblastoma of the central nervous system. J Neuropathol Exp Neurol 73:50\u201358. doi: 10.1097\/NEN.0000000000000024","journal-title":"J Neuropathol Exp Neurol"},{"key":"1983_CR7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ajcp\/107.4.459","volume":"107","author":"JY Tse","year":"1997","unstructured":"Tse JY, Wong JH, Lo KW, Poon WS, Huang DP, Ng HK (1997) Molecular genetic analysis of the von Hippel\u2013Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas. Am J Clin Pathol 107:459\u2013466","journal-title":"Am J Clin Pathol"},{"key":"1983_CR8","first-page":"504","volume":"58","author":"JY Lee","year":"1998","unstructured":"Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, Chi JG, Zbar B, Lubensky IA, Linehan WM, Vortmeyer AO, Zhuang Z (1998) Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 58:504\u2013508","journal-title":"Cancer Res"},{"key":"1983_CR9","first-page":"765","volume":"60","author":"AH Prowse","year":"1997","unstructured":"Prowse AH, Webster AR, Richards FM, Richard S, Olschwang S, Resche F, Affara NA, Maher ER (1997) Somatic inactivation of the VHL gene in Von Hippel\u2013Lindau disease tumors. Am J Hum Genet 60:765\u2013771","journal-title":"Am J Hum Genet"},{"key":"1983_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s40478-014-0167-x","volume":"2","author":"GM Shankar","year":"2014","unstructured":"Shankar GM, Taylor-Weiner A, Lelic N, Jones RT, Kim JC, Francis JM, Abedalthagafi M, Borges LF, Coumans JV, Curry WT, Nahed BV, Shin JH, Paek SH, Park SH, Stewart C, Lawrence MS, Cibulskis K, Thorner AR, Van Hummelen P, Stemmer-Rachamimov AO, Batchelor TT, Carter SL, Hoang MP, Santagata S, Louis DN, Barker FG, Meyerson M, Getz G, Brastianos PK, Cahill DP (2014) Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun 2:167. doi: 10.1186\/s40478-014-0167-x","journal-title":"Acta Neuropathol Commun"},{"key":"1983_CR11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199606)179:2<151::AID-PATH556>3.0.CO;2-0","volume":"179","author":"J Oberstrass","year":"1996","unstructured":"Oberstrass J, Reifenberger G, Reifenberger J, Wechsler W, Collins VP (1996) Mutation of the Von Hippel\u2013Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system. J Pathol 179:151\u2013156","journal-title":"J Pathol"},{"key":"1983_CR12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<424::AID-HUMU9>3.0.CO;2-H","volume":"12","author":"S Olschwang","year":"1998","unstructured":"Olschwang S, Richard S, Boisson C, Giraud S, Laurent-Puig P, Resche F, Thomas G (1998) Germline mutation profile of the VHL gene in von Hippel\u2013Lindau disease and in sporadic hemangioblastoma. Hum Mutat 12:424\u2013430. doi: 10.1002\/(SICI)1098-1004(1998)12:6<424:AID-HUMU9>3.0.CO;2-H","journal-title":"Hum Mutat"},{"key":"1983_CR13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jnnp.70.5.644","volume":"70","author":"S Glasker","year":"2001","unstructured":"Glasker S, Bender BU, Apel TW, van Velthoven V, Mulligan LM, Zentner J, Neumann HP (2001) Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry 70:644\u2013648","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1983_CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1010623119469","volume":"52","author":"SH Sprenger","year":"2001","unstructured":"Sprenger SH, Gijtenbeek JM, Wesseling P, Sciot R, van Calenbergh F, Lammens M, Jeuken JW (2001) Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization. J Neurooncol 52:241\u2013247","journal-title":"J Neurooncol"},{"key":"1983_CR15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnen\/63.10.1072","volume":"63","author":"S Lemeta","year":"2004","unstructured":"Lemeta S, Pylkkanen L, Sainio M, Niemela M, Saarikoski S, Husgafvel-Pursiainen K, Bohling T (2004) Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas. J Neuropathol Exp Neurol 63:1072\u20131079","journal-title":"J Neuropathol Exp Neurol"},{"key":"1983_CR16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1215\/S1152851705000025","volume":"7","author":"MA Proescholdt","year":"2005","unstructured":"Proescholdt MA, Mayer C, Kubitza M, Schubert T, Liao SY, Stanbridge EJ, Ivanov S, Oldfield EH, Brawanski A, Merrill MJ (2005) Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro-oncology 7:465\u2013475. doi: 10.1215\/S1152851705000025","journal-title":"Neuro-oncology"},{"key":"1983_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)65541-1","volume":"153","author":"I Flamme","year":"1998","unstructured":"Flamme I, Krieg M, Plate KH (1998) Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF\/HIF-2alpha. Am J Pathol 153:25\u201329","journal-title":"Am J Pathol"},{"key":"1983_CR18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","volume":"2","author":"WG Kaelin Jr","year":"2002","unstructured":"Kaelin WG Jr (2002) Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2:673\u2013682","journal-title":"Nat Rev Cancer"},{"key":"1983_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMoa073123","volume":"358","author":"MJ Percy","year":"2008","unstructured":"Percy MJ, Furlow PW, Lucas GS, Li X, Lappin TR, McMullin MF, Lee FS (2008) A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. N Eng J Med 358:162\u2013168. doi: 10.1056\/NEJMoa073123","journal-title":"N Eng J Med"},{"key":"1983_CR20","doi-asserted-by":"crossref","first-page":"E908","DOI":"10.1210\/jc.2013-1217","volume":"98","author":"D Taieb","year":"2013","unstructured":"Taieb D, Yang C, Delenne B, Zhuang Z, Barlier A, Sebag F, Pacak K (2013) First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome. J Clin Endocrinol Metab 98:E908\u2013E913. doi: 10.1210\/jc.2013-1217","journal-title":"J Clin Endocrinol Metab"},{"key":"1983_CR21","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2012-10-460972","volume":"121","author":"C Yang","year":"2013","unstructured":"Yang C, Sun MG, Matro J, Huynh TT, Rahimpour S, Prchal JT, Lechan R, Lonser R, Pacak K, Zhuang Z (2013) Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas. Blood 121:2563\u20132566. doi: 10.1182\/blood-2012-10-460972","journal-title":"Blood"},{"key":"1983_CR22","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","volume":"367","author":"Z Zhuang","year":"2012","unstructured":"Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, Pacak K (2012) Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med 367:922\u2013930. doi: 10.1056\/NEJMoa1205119","journal-title":"N Engl J Med"},{"key":"1983_CR23","author":"K Pacak","year":"2014","unstructured":"Pacak K, Chew EY, Pappo AS, Yang C, Lorenzo FR, Wilson MW, Aronow MB, Young JA, Popovic V, Zhuang Z (2014) Ocular manifestations of hypoxia-inducible factor-2\u03b1 paraganglioma-somatostatinoma-polycythemia syndrome. Ophthalmology. doi: 10.1016\/j.ophtha.2014.06.019","journal-title":"Ophthalmology"},{"key":"1983_CR24","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","volume":"31","author":"K Pacak","year":"2013","unstructured":"Pacak K, Jochmanova I, Prodanov T, Yang C, Merino MJ, Fojo T, Prchal JT, Tischler AS, Lechan RM, Zhuang Z (2013) New syndrome of paraganglioma and somatostatinoma associated with polycythemia. J Clin Oncol 31:1690\u20131698. doi: 10.1200\/JCO.2012.47.1912","journal-title":"J Clin Oncol"},{"key":"1983_CR25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-13-0384","volume":"21","author":"J Welander","year":"2014","unstructured":"Welander J, Andreasson A, Brauckhoff M, Backdahl M, Larsson C, Gimm O, Soderkvist P (2014) Frequent EPAS1\/HIF2alpha exons 9 and 12 mutations in non-familial pheochromocytoma. Endocr Relat Cancer 21:495\u2013504. doi: 10.1530\/ERC-13-0384","journal-title":"Endocr Relat Cancer"},{"key":"1983_CR26","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","volume":"22","author":"I Comino-Mendez","year":"2013","unstructured":"Comino-Mendez I, de Cubas AA, Bernal C, Alvarez-Escola C, Sanchez-Malo C, Ramirez-Tortosa CL, Pedrinaci S, Rapizzi E, Ercolino T, Bernini G, Bacca A, Leton R, Pita G, Alonso MR, Leandro-Garcia LJ, Gomez-Grana A, Inglada-Perez L, Mancikova V, Rodriguez-Antona C, Mannelli M, Robledo M, Cascon A (2013) Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. Hum Mol Genet 22:2169\u20132176. doi: 10.1093\/hmg\/ddt069","journal-title":"Hum Mol Genet"},{"key":"1983_CR27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","volume":"1","author":"K Kondo","year":"2002","unstructured":"Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin WG Jr (2002) Inhibition of HIF is necessary for tumor suppression by the von Hippel\u2013Lindau protein. Cancer Cell 1:237\u2013246","journal-title":"Cancer Cell"},{"key":"1983_CR28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00109-012-0967-z","volume":"91","author":"FR Lorenzo","year":"2013","unstructured":"Lorenzo FR, Yang C, Ng Tang Fui M, Vankayalapati H, Zhuang Z, Huynh T, Grossmann M, Pacak K, Prchal JT (2013) A novel EPAS1\/HIF2A germline mutation in a congenital polycythemia with paraganglioma. J Mol Med 91:507\u2013512. doi: 10.1007\/s00109-012-0967-z","journal-title":"J Mol Med"},{"key":"1983_CR29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.celrep.2012.12.007","volume":"3","author":"C Yang","year":"2013","unstructured":"Yang C, Huntoon K, Ksendzovsky A, Zhuang Z, Lonser RR (2013) Proteostasis modulators prolong missense VHL protein activity and halt tumor progression. Cell Rep 3:52\u201359. doi: 10.1016\/j.celrep.2012.12.007","journal-title":"Cell Rep"},{"key":"1983_CR30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/ERC-13-0101","volume":"20","author":"RA Toledo","year":"2013","unstructured":"Toledo RA, Qin Y, Srikantan S, Morales NP, Li Q, Deng Y, Kim SW, Pereira MA, Toledo SP, Su X, Aguiar RC, Dahia PL (2013) In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas. Endocr Relat Cancer 20:349\u2013359. doi: 10.1530\/ERC-13-0101","journal-title":"Endocr Relat Cancer"},{"key":"1983_CR31","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/MCB.01514-06","volume":"27","author":"Q Yan","year":"2007","unstructured":"Yan Q, Bartz S, Mao M, Li L, Kaelin WG Jr (2007) The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo. Mol Cell Biol 27:2092\u20132102. doi: 10.1128\/MCB.01514-06","journal-title":"Mol Cell Biol"},{"key":"1983_CR32","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jnci\/djt201","volume":"105","author":"I Jochmanova","year":"2013","unstructured":"Jochmanova I, Yang C, Zhuang Z, Pacak K (2013) Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst 105:1270\u20131283. doi: 10.1093\/jnci\/djt201","journal-title":"J Natl Cancer Inst"},{"key":"1983_CR33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458:719\u2013724. doi: 10.1038\/nature07943","journal-title":"Nature"},{"key":"1983_CR34","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","volume":"22","author":"WY Kim","year":"2004","unstructured":"Kim WY, Kaelin WG (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22:4991\u20135004. doi: 10.1200\/JCO.2004.05.061","journal-title":"J Clin Oncol"},{"key":"1983_CR35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/modpathol.2011.61","volume":"24","author":"SB Shively","year":"2011","unstructured":"Shively SB, Falke EA, Li J, Tran MG, Thompson ER, Maxwell PH, Roessler E, Oldfield EH, Lonser RR, Vortmeyer AO (2011) Developmentally arrested structures preceding cerebellar tumors in von Hippel\u2013Lindau disease. Mod Pathol 24:1023\u20131030. doi: 10.1038\/modpathol.2011.61","journal-title":"Mod Pathol"},{"key":"1983_CR36","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1038\/onc.2008.160","volume":"27","author":"EB Rankin","year":"2008","unstructured":"Rankin EB, Rha J, Unger TL, Wu CH, Shutt HP, Johnson RS, Simon MC, Keith B, Haase VH (2008) Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 27:5354\u20135358. doi: 10.1038\/onc.2008.160","journal-title":"Oncogene"},{"key":"1983_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","volume":"12","author":"B Keith","year":"2012","unstructured":"Keith B, Johnson RS, Simon MC (2012) HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12:9\u201322. doi: 10.1038\/nrc3183","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1983-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-1983-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1983-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T02:49:59Z","timestamp":1567306199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-1983-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1983"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-1983-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]}}}